About Carbohydrate sulfotransferase 1
Carbohydrate sulfotransferase 1 (CHST1) is a protein
from Homo sapiens identified by UniProt accession
O43916, 411 residues long.
MolForge cross-references it against 0 known binders and
43 disease associations.
Target properties
| Protein name | Carbohydrate sulfotransferase 1 |
| UniProt accession | O43916 |
| Gene | CHST1 |
| Organism | Homo sapiens |
| Length | 411 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (43)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.33
- gut microbiome measurement · score 0.31
- Abnormality of refraction · score 0.30
- type 2 diabetes mellitus · score 0.14
- mathematical ability · score 0.11
- body mass index · score 0.09
- insomnia measurement · score 0.06
- age at menarche · score 0.05
- neutropenia, severe congenital, 2, autosomal dominant · score 0.04
- combined immunodeficiency with skin granulomas · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O43916-F1 | alphafold | PREDICTED | 87.43 | — |
Amino-acid sequence (411 residues)
MQCSWKAVLL LALASIAIQY TAIRTFTAKS FHTCPGLAEA GLAERLCEES PTFAYNLSRK THILILATTR SGSSFVGQLF NQHLDVFYLF EPLYHVQNTL IPRFTQGKSP ADRRVMLGAS RDLLRSLYDC DLYFLENYIK PPPVNHTTDR IFRRGASRVL CSRPVCDPPG PADLVLEEGD CVRKCGLLNL TVAAEACRER SHVAIKTVRV PEVNDLRALV EDPRLNLKVI QLVRDPRGIL ASRSETFRDT YRLWRLWYGT GRKPYNLDVT QLTTVCEDFS NSVSTGLMRP PWLKGKYMLV RYEDLARNPM KKTEEIYGFL GIPLDSHVAR WIQNNTRGDP TLGKHKYGTV RNSAATAEKW RFRLSYDIVA FAQNACQQVL AQLGYKIAAS EEELKNPSVS LVEERDFRPF S
Explore Carbohydrate sulfotransferase 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets